STOCK TITAN

EBS (NYSE: EBS) insider files Rule 144 to sell 104,695 shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

EBS has filed a notice under Rule 144 for a proposed sale of 104,695 shares of common stock, with an aggregate market value of $1,336,462.98. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an approximate sale date of 12/22/2025. The issuer had 52,519,964 shares of common stock outstanding, providing context for the size of this planned sale. The securities being sold were originally acquired as restricted stock on 05/18/2016 and as exercised shares on 05/10/2021, both from the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many EBS shares are planned to be sold under this Rule 144 notice?

The notice covers the planned sale of 104,695 shares of common stock with an aggregate market value of $1,336,462.98.

On which exchange and around what date will the EBS shares be sold?

The shares are expected to be sold on the NYSE with an approximate sale date of 12/22/2025.

Who is the broker handling the planned EBS share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

How many EBS shares were outstanding at the time of this filing?

The issuer had 52,519,964 shares of common stock outstanding, which provides context for the relative size of the 104,695-share planned sale.

How were the EBS shares being sold originally acquired?

The securities consist of restricted stock acquired on 05/18/2016 in the amount of 94,390 shares and exercised shares acquired on 05/10/2021 in the amount of 10,305 shares, both from the issuer.

What does the signer of the EBS Rule 144 notice represent about company information?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

Emergent Biosolutions Inc

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Latest SEC Filings

EBS Stock Data

652.30M
50.96M
2.84%
70.19%
16.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
GAITHERSBURG